Annovis Bio Inc. (ANVS) Social Stream



Annovis Bio Inc. (ANVS): $8.90

0.20 (-2.20%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

ANNOVIS BIO INC (ANVS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ANVS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-22 1 $70 $70 $70 $9.1 669.23%
2022-04-08 1 $26 $26 $26 $9.1 185.71%
2022-08-09 2 $37 $26 $31.5 $9.1 246.15%
2023-04-04 3 $72 $26 $46 $9.1 405.49%
2023-08-17 2 $72 $40 $56 $9.1 515.38%

The Trend in the Analyst Price Target


Over the past 40 weeks, ANVS's average price target has gone up $10.

ANVS reports an average of 288.88% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-30 3 72 26 46 17.22 167.13%
2023-02-08 3 72 26 46 19.14 140.33%
2023-04-04 3 72 26 46 11.95 284.94%
2023-08-15 2 72 40 56 12.83 336.48%
2023-08-17 2 72 40 56 12.77 338.53%

ANVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 52 weeks, ANVS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, ANNOVIS BIO INC's number of analysts covering the stock is higher than 17.08% of them.
  • In terms of how ANNOVIS BIO INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 532.78% of that group.
  • ANNOVIS BIO INC's variance in analysts' estimates is lower than -29.34% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, ANNOVIS BIO INC's average analyst price target is higher than 486.35% of them.

Stocks similar to ANNOVIS BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ETNB, GRTX, and RAPT.

Is ANVS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!